UBS AM’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,600,000
Closed -$3.02M 2646
2025
Q1
$3.02M Buy
2,600,000
+1,430,000
+122% +$1.66M ﹤0.01% 1810
2024
Q4
$1.49M Buy
1,170,000
+272,467
+30% +$346K ﹤0.01% 2184
2024
Q3
$3.06M Sell
897,533
-4,090
-0.5% -$13.9K ﹤0.01% 1813
2024
Q2
$4.21M Buy
901,623
+818,056
+979% +$3.82M ﹤0.01% 1586
2024
Q1
$620K Sell
83,567
-9,383
-10% -$69.6K ﹤0.01% 2218
2023
Q4
$942K Hold
92,950
﹤0.01% 2054
2023
Q3
$725K Buy
92,950
+19,449
+26% +$152K ﹤0.01% 2135
2023
Q2
$533K Hold
73,501
﹤0.01% 2298
2023
Q1
$533K Buy
73,501
+6,822
+10% +$49.5K ﹤0.01% 2298
2022
Q4
$591K Buy
66,679
+4,648
+7% +$41.2K ﹤0.01% 2106
2022
Q3
$759K Buy
62,031
+10,347
+20% +$127K ﹤0.01% 2126
2022
Q2
$611K Sell
51,684
-11,402
-18% -$135K ﹤0.01% 2224
2022
Q1
$1.2M Hold
63,086
﹤0.01% 2037
2021
Q4
$1.67M Sell
63,086
-4,547
-7% -$121K ﹤0.01% 1954
2021
Q3
$2.78M Buy
67,633
+3,050
+5% +$125K ﹤0.01% 1683
2021
Q2
$3.66M Buy
64,583
+7,295
+13% +$413K ﹤0.01% 1532
2021
Q1
$2.41M Sell
57,288
-11,494
-17% -$483K ﹤0.01% 1681
2020
Q4
$4.82M Buy
68,782
+11,753
+21% +$824K ﹤0.01% 1312
2020
Q3
$1.6M Buy
57,029
+9,323
+20% +$262K ﹤0.01% 1641
2020
Q2
$1.41M Buy
47,706
+5,670
+13% +$168K ﹤0.01% 1660
2020
Q1
$834K Buy
42,036
+14,240
+51% +$282K ﹤0.01% 1770
2019
Q4
$823K Buy
27,796
+1,327
+5% +$39.3K ﹤0.01% 2012
2019
Q3
$602K Buy
26,469
+12,069
+84% +$274K ﹤0.01% 2197
2019
Q2
$356K Hold
14,400
﹤0.01% 2350
2019
Q1
$352K Sell
14,400
-167,921
-92% -$4.11M ﹤0.01% 2251
2018
Q4
$4.15M Sell
182,321
-16,172
-8% -$368K ﹤0.01% 1154
2018
Q3
$6.32M Sell
198,493
-427
-0.2% -$13.6K ﹤0.01% 1068
2018
Q2
$7.13M Buy
198,920
+37,959
+24% +$1.36M 0.01% 1036
2018
Q1
$5.34M Sell
160,961
-85,240
-35% -$2.83M ﹤0.01% 1120
2017
Q4
$7.57M Buy
+246,201
New +$7.57M 0.01% 989